TABLE 1. Baseline characteristics of the enrolled patients.

Parameters	Total 103 (100%)	HCC 45 (44%)	Non-HCC 58 (66%)	p
Age (y)	53±11.5	54.1±12.2	52.1±11.0	0.448
Gender (M/F) %	68/32	69/31	68/32	>0.05
Etiology % HCV OH HBV NASH Cryptogenic CBS Auto immune Others	35 29 8 7 6 5 3 7	51 4 18 4 4 2 7 5	21 50 0 9 7 7 0 7	<0.001
MELD score Mean Median	14.7±6.4 14 (6-32)	14.7±7.0 12 (6-30)	14.7±6.0 14 (6-32)	0.693
CPT A/B/C %	38/47/15	43/45/12	35/50/15	0.801
AFP (≥20 ng/ml) %	25.7	38.9	10.3	0.011
AFP (≥9.1 ng/ml) %	33.3	50	13.7	0.003
PH-CB %	83.9	73.6	91.7	0.038

Mean and standard deviation; numbers and percentage; PH-CB=portal hypertension clinically-based; MELD= Model for End Stage Liver Disease; AFP=alpha fetoprotein; HCC=hepatocellular carcinoma; CPT =Child-Turcotte-Pugh; HCB=hepatites C vírus infection; NASH=nonalcoholic steatohepatitis; OH=alcoholic hepatitis; HBV=B virus infection; CBS=secondary biliary cirrhosis